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Abstract
Background: Chloride currents in peripheral nociceptive neurons have been implicated in the generation of
afferent nociceptive signals, as Cl- accumulation in sensory endings establishes the driving force for depolarizing,
and even excitatory, Cl- currents. The intracellular Cl- concentration can, however, vary considerably between
individual DRG neurons. This raises the question, whether the contribution of Cl- currents to signal generation
differs between individual afferent neurons, and whether the specific Cl- levels in these neurons are subject to
modulation. Based on the hypothesis that modulation of the peripheral Cl- homeostasis is involved in the
generation of inflammatory hyperalgesia, we examined the effects of inflammatory mediators on intracellular Cl-
concentrations and on the expression levels of Cl- transporters in rat DRG neurons.
Results: We developed an in vitro assay for testing how inflammatory mediators influence Cl- concentration and
the expression of Cl- transporters. Intact DRGs were treated with 100 ng/ml NGF, 1.8 μM ATP, 0.9 μM
bradykinin, and 1.4 μM PGE2 for 1–3 hours. Two-photon fluorescence lifetime imaging with the Cl--sensitive dye
MQAE revealed an increase of the intracellular Cl- concentration within 2 hours of treatment. This effect
coincided with enhanced phosphorylation of the Na+-K+-2Cl- cotransporter NKCC1, suggesting that an increased
activity of that transporter caused the early rise of intracellular Cl- levels. Immunohistochemistry of NKCC1 and
KCC2, the main neuronal Cl- importer and exporter, respectively, exposed an inverse regulation by the
inflammatory mediators. While the NKCC1 immunosignal increased, that of KCC2 declined after 3 hours of
treatment. In contrast, the mRNA levels of the two transporters did not change markedly during this time. These
data demonstrate a fundamental transition in Cl- homeostasis toward a state of augmented Cl- accumulation,
which is induced by a 1–3 hour treatment with inflammatory mediators.
Conclusion: Our findings indicate that inflammatory mediators impact on Cl- homeostasis in DRG neurons.
Inflammatory mediators raise intracellular Cl- levels and, hence, the driving force for depolarizing Cl- efflux. These
findings corroborate current concepts for the role of Cl- regulation in the generation of inflammatory hyperalgesia
and allodynia. As the intracellular Cl- concentration rises in DRG neurons, afferent signals can be boosted by
excitatory Cl- currents in the presynaptic terminals. Moreover, excitatory Cl- currents in peripheral sensory
endings may also contribute to the generation or modulation of afferent signals, especially in inflamed tissue.
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Background
The regulation of intracellular chloride, [Cl-]i, in DRG
neurons has a distinct impact on the detection and trans-
mission of the peripheral nociceptive signals. Measure-
ments with isolated DRG neurons have shown that Cl- is
accumulated into the cytoplasm, supporting a Cl- equilib-
rium potential, ECl, near -40 mV [1-3]. The opening of Cl-
permeable channels, therefore, induces a depolarizing Cl-
efflux. Presynaptic GABAA receptors in the dorsal horn
conduct Cl- efflux and cause primary afferent depolariza-
tion (PAD) [4,5]. PAD mediates presynaptic inhibition of
nociceptive afferents, but intense afferent stimulation can
cause excitatory Cl- efflux which contributes to dorsal root
reflexes, hyperalgesia, and neurogenic inflammation [4-
8]. In addition to these well-characterized spinal proc-
esses, excitatory Cl- effects were also reported for the cuta-
neous endings of nociceptors [9,10]. Together, these
observations raise the possibility that depolarizing Cl- cur-
rents contribute to signal generation in the periphery as
well as to synaptic transmission. Interestingly, [Cl-]i can
increase under certain conditions, as was recently reported
for nociceptors upon nerve damage and regeneration (e.g.
from 31 to 68 mM [11]). A rising level of [Cl-]i is expected
to amplify peripheral and presynaptic Cl- efflux and its
effect on sensory signal generation and transmission. As a
consequence of these findings, the regulation of Cl- trans-
port proteins has become an important topic of nocicep-
tor research [12]. Indeed, a number of recent studies has
documented a link between pain behaviour and Cl- accu-
mulation in cutaneous and visceral nociceptors. Genetic
ablation of the Na+-K+-2Cl- cotransporter NKCC1 was
associated with reduced Cl- accumulation in DRG neurons
and caused a reduced thermal nociceptive response [13]
as well as attenuation of Aβ-mediated allodynia [14].
TRPV1-dependent, referred abdominal allodynia [15],
itch and flare responses [16], as well as nocifensive behav-
iour in phase II of the formalin test [17], were all inhibited
upon spinal or peripheral application of the NKCC1-
inhibitor bumetanide. Similarly, dorsal root reflexes and
neurogenic inflammation were attenuated by intrathecal
bumetanide injection [18].
Cl- regulation in neurons is mediated by cation-coupled
Cl--cotransporters (CCCs) [19-21]. NKCC1 (SLC12A2) is
the main key player of active Cl- uptake. In contrast, Cl-
extrusion in neurons is mediated by the K+-Cl- cotrans-
porter KCC2 (SLC12A5). For DRG neurons, the expres-
sion of NKCC1 is well documented [13,22], while the
expression of KCC2 is controversial [23,24]. The intracel-
lular Cl- concentration in neurons is mainly determined
by the functional expression of these CCCs. In addition,
regulatory mechanisms that control the activity of Cl-
transporters include phosphorylation [25-27] and dimer-
ization [28]. Importantly, small shifts in the balance
between Cl- import and Cl- extrusion can cause changes of
ECl which substantially alter a neuron's response to the
opening of Cl- channels. A recent approach to model the
GABAergic response of a spinal lamina 1 neuron revealed
that a shift of ECl as small as 10 mV to less negative values
is sufficient to turn GABA-induced currents from inhibi-
tory to excitatory [29]. Interestingly, a recent thermody-
namic analysis of Cl- transport in DRG neurons indicated
that the regulation of NKCC1 activity by phosphoryla-
tion/dephosphorylation may account for substantial
changes in ECl [3]. Thus, Cl- levels in DRG neurons are
probably not constant, but they are subject to regulation.
Processes that control the dynamics of Cl- accumulation,
consequently, play an important role in current concepts
for the plasticity of the afferent pain pathway
[3,5,8,12,30-35].
Here we examined the hypothesis that [Cl-]i is modulated
by factors involved in inflammatory hyperalgesia. We
studied the effects of inflammatory mediators on the
intracellular Cl- concentration as well as on the expression
of NKCC1 and KCC2. We used an in vitro assay to monitor
Cl- concentrations in intact, freshly dissected DRGs by
two-photon fluorescence lifetime imaging microscopy
(2P-FLIM). We find that inflammatory mediators cause an
increase of Cl- levels in DRG neurons which correlates
with enhanced NKCC1 expression and decreased KCC2
expression.
Results
In vitro assay for monitoring effects of 
inflammatorymediators
Our objective was to monitor changes of the intracellular
Cl-  concentration as well as changes in expression of
NKCC1 and KCC2 in the presence of inflammatory medi-
ators. To minimize damage to the neurons and to avoid
dedifferentiation effects that may alter Cl- homeostasis in
cell culture, we examined the neurons in rat DRGs with
intact dura mater. The DRGs were excised and immediately
used for the assay which was concluded within < 4 hr post
mortem. The excised DRGs were incubated with a combi-
nation of inflammatory mediators (100 ng/ml NGF, 1.8
μM ATP, 0.9 μM bradykinin, 1.4 μM PGE2) for 1, 2, or 3
hr at 37°C, and then either subjected to 2P-FLIM analysis
or fixed for immunohistochemistry. The vitality of DRG
neurons during this procedure was tested in DRG tissue
slices using propidium-iodide exclusion and resazurin-
reduction assays (see Methods). Both tests confirmed a
cell viability of > 95% within the 3-hr period of experi-
mentation with and without the inflammatory mediators
(not shown). To find out whether the DRG neurons
responded to the inflammatory mediators, we analyzed
the immunosignals of the neuropeptides CGRP and sub-
stance P (SP) which are known to be upregulated during
inflammation [e.g. [36-38]]. We compared the relative
numbers of neuropeptide-expressing neurons in DRGsMolecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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treated with inflammatory mediators to control DRGs
from the same animal treated with exactly the same pro-
tocol, but without the inflammatory mediators. In 9 con-
trol DRGs (T7-T9) from 3 animals, we found on average
35% of the neurons expressing CGRP and 33% expressing
SP. The 9 corresponding contralateral test DRGs were
treated with inflammatory mediators for 1 hr (3 T7-DRGs
from 3 rats), 2 hr (3 T8-DRGs), or 3 hr (3 T9-DRGs). We
determined the relative number of neuropeptide-positive
cells separately for each control DRG (NPctr) and for its
contralateral test DRG (NPtest), and we quantified the per-
cent change of neuropeptide-positive neurons according
to Δ NP = (NPtest-NPctr)/NPctr·100 [%]. Fig. 1A illustrates
the time-dependent increase of neuropeptide-positive
neurons in the treated ganglia. Δ NP (± SD; 3 animals) was
4 ± 2% (1 hr), 10 ± 4% (2 hr), and 29 ± 5% (3 hr) for
CGRP, and 6 ± 7% (1 hr), 18 ± 5% (2 hr), and 34 ± 10%
(3 hr) for SP. In total, 5329 control cells and 4596 test
cells were counted for the CGRP statistics, and 3178 con-
trol cells and 3467 treated cells for SP. These data show
that the DRG neurons in our in vitro assay respond to the
inflammatory mediators with enhanced synthesis of neu-
ropeptides, a behaviour which is indicative of an inflam-
matory response in vivo. To monitor changes of [Cl-]i
between control and treated DRGs we examined the Cl--
dependent fluorescence of MQAE by 2P-FLIM immedi-
ately after the test time of 1, 2, or 3 hours, as described
below.
For immunohistochemical studies, we prepared cryosec-
tions of the control DRGs and of test DRGs and stained
the cells with antibodies directed against NKCC1 or
KCC2. We then evaluated the mean fluorescence intensity
of each immunostained DRG neuron as described in
Methods. Fig. 1B shows fluorescence images to illustrate
the evaluation procedure. Following background subtrac-
tion, the mean fluorescence intensity of each intact and
uniformly stained cell in a section was measured using
identical imaging parameters. This analysis resulted in a
pair of histograms (control and test) of the cell fluores-
cence intensities for each treatment time (Fig. 1C; exam-
ple for 3 hr). The mean fluorescence intensities in control
DRGs (FIctr) and corresponding test DRGs (FItest) were
determined by Gaussian fits to the histograms and were
used to quantify the percent change of immune fluores-
In vitro assay to study the effects of inflammatory mediators by immunohistochemistry Figure 1
In vitro assay to study the effects of inflammatory mediators by immunohistochemistry. (A) Increased expression 
of neuropeptides during treatment with inflammatory mediators. The immunfluorescence of calcitonin gene-related peptide 
(CGRP) and substance P (SP) was evaluated at the indicated times after start of the treatment. The relative number of neu-
ropeptide-expressing neurons was determined in test DRGs and in contralateral control DRGs, and the percent change of 
positive cells, Δ NP = (NPtest-NPctr)/NPctr·100 [%], is given for each time. Indicated significance levels are p ≤ 0.05 (*) or p ≤ 
0.01 (**). (B) Cryosections of a control DRG and the treated contralateral test DRG stained with NKCC1 antibodies. The red 
circles illustrate the area from which the mean fluorescence intensity was obtained. Background subtraction removed most of 
the pericellular fluorescence as well as the fluorescence originating from the nucleus. All cell sections with intact perimeter 
were evaluated. (C) Distribution of fluorescence intensities recorded from 3 control DRGs (blue) and 3 contralateral test 
DRGs (red) illustrate a shift to higher intensities after a 3-hr treatment with inflammatory mediators. Solid lines are Gaussian 
fits to the data.Molecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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cence ΔFI = (FItest-FIctr)/FIctr·100 [%] upon treatment with
inflammatory mediators.
Inflammatory mediators cause enhanced Cl- accumulation
To look for changes of the intracellular Cl- concentration
during exposure to inflammatory mediators, we loaded
the DRG neurons with the Cl--sensitive fluorescent dye
MQAE. MQAE fluorescence is quenched by Cl- and can
therefore be used to monitor time-dependent changes of
the intracellular Cl-  level. To obtain an experimental
parameter which depends only on changes of intracellular
Cl-, we analyzed the fluorescence lifetime of MQAE [39-
41]. Recordings were taken from intact DRGs (T7 – T9) by
focusing the light of a two-photon microscope through
the dura mater into cell layers 20 – 100 μm deep in the
DRG. The recorded fluorescence lifetime was colour-
coded for the microscopic images such that warmer col-
ours represent higher Cl- concentrations (Fig. 2A). We did
not attempt to calibrate the 2P-FLIM signals in terms of
absolute Cl- concentrations (see Discussion). We used the
inverse of the fluorescence lifetime τ (LT = 1/τ) as a
parameter that is proportional to the Cl- concentration,
according to 1/τ = 1/τ0 + (KSV [Cl-]i)/τ0, where τ0 is the
value of τ in Cl--free solution, and KSV is the Stern-Volmer
constant. Fig. 2A illustrates that the Cl- levels rise in most
DRG neurons 2 hr after addition of the inflammatory
mediators, and show a further increase after another hour.
For the 2P-FLIM analysis, 18 DRGs (9 treated, 9 control)
from 6 animals (in total, 365 control cells and 361 test
cells) were evaluated. For each treatment time, the mean
inverse lifetime, LT, was determined for all neurons in a
control DRG (LTctr) and the contralateral test DRG (LTtest).
Corresponding to our evaluation of immunostains, we
determined the percent increase of LT as ΔLT = (LTtest-
LTctr)/LTctr·100 [%]. The data in Fig. 2B demonstrate that
Cl- increased significantly within 2 hr of treatment with
(A) Two-photon fluorescence lifetime imaging microscopy (2P-FLIM) of intact DRGs loaded with the chloride indicator dye  MQAE Figure 2
(A) Two-photon fluorescence lifetime imaging microscopy (2P-FLIM) of intact DRGs loaded with the chloride indicator dye 
MQAE. The colour code indicates the fluorescence lifetime (τ) which is inversely proportional to the Cl- concentration. Warm 
colours represent high intracellular Cl- concentration (small τ values). (B) Quantitative evaluation of 2P-FLIM data show a highly 
significant increase of the inverse lifetime (LT = 1/τ) two hours after the start of treament with inflammatory mediators. Mean 
LT values were determined in control DRGs (LTctr) and in contralateral test DRGs (LTtest), and the percent increase of LT is 
depicted as ΔLT = (LTtest-LTctr)/LTctr·100 [%] for each treatment time. Indicated significance levels are p ≤ 0.05 (*) or p ≤ 0.01 
(**).Molecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
Page 5 of 12
(page number not for citation purposes)
inflammatory mediators. ΔLT (± SD; 3 animals) was -0.3
± 1.2% (1 hr), 7.7 ± 0.9% (2 hr), and 10.3 ± 5.3% (3 hr).
Moreover, the 2P-FLIM measurements revealed that virtu-
ally all DRG neurons visible in the images increase their
intracellular Cl- concentrations in response to the inflam-
matory stimulus. Thus, DRG neurons respond to inflam-
matory mediators more or less uniformly by boosting the
driving force for depolarizing Cl- efflux.
Changes in expression of Cl- transporters correlate with Cl-
accumulation
We tested for possible effects of the inflammatory media-
tors on the transcription of NKCC1 and KCC2 by semi-
quantitative PCR analysis of the respective mRNAs. Over
the 3-hr time course of the experiments, we did not detect
any change in mRNA levels of either Cl- transporter (data
not shown). This observation suggests that the enhanced
Cl- accumulation is not the consequence of transcriptional
upregulation of NKCC1 or the downregulation of KCC2
transcription. To study effects of the treatment with
inflammatory mediators on the protein level, we per-
formed quantitative immunohistochemistry on 18 T7-T9
DRGs (9 control, 9 treated) from 3 animals. We stained
cryosections with antibodies raised against NKCC1 and
KCC2, and we compared the mean fluorescence intensity
of the stained neurons in each test DRG (FItest) to that of
the corresponding contralateral control DRG (FIctr). Care
was taken to include all intact cell sections with fluores-
cence above background, so as not to introduce any bias
into the evaluation procedure. The results are give as per-
cent change of fluorescence intensity, ΔFI = (FItest-FIctr)/
FIctr·100 [%]. ΔFI (± SD; 3 animals) was 4.3 ± 7.2% (1 hr),
2 ± 7.2% (2 hr), and 30 ± 4.35% (3 hr) for NKCC1, and -
5 ± 12.4% (1 hr), 7 ± 4.6% (2 hr), and -15 ± 3.5% (3 hr)
for KCC2 (Fig. 3A). These data demonstrate that NKCC1
and KCC2 expression levels remain unchanged over 2 hr
of treatment with inflammatory mediators. After 3 hr,
however, the expression level of KCC2 dropped signifi-
cantly while that of NKCC1 increased. While the changes
in NKCC1 and KCC2 expression are consistent with
increased Cl- accumulation, the time course of the expres-
sion changes lags behind the rise in [Cl-]i. Cl- accumula-
tion increases already after 2 hr (Fig. 2B) when the co-
transporters are still at control level. To exclude any bias
that might originate from our "segment pairs" analysis,
we repeated the measurements and compared 6 control
DRGs to 6 treated DRGs from different vertebral seg-
ments. In these experiments, ΔFI (± SD; 3 animals) was -4
± 8% (2 hr) and 32 ± 3% (3 hr) for NKCC1, and 0 ± 12%
(2 hr) and -26 ± 8,5% (3 hr) for KCC2 (Fig. 3B). Thus, the
"random pairs" protocol yielded the same result, with sig-
nificant effects on the co-transporter expression only after
3 hr. These results demonstrate that inflammatory media-
tors induce a change in the regime of Cl- handling in DRG
neurons with a delay of 3 hr after the start of the inflam-
matory treatment. The effect of the mediators is consistent
with increased Cl- accumulation, as NKCC1 expression is
enhanced, while KCC2 expression is attenuated.
The early rise of intracellular Cl- levels coincides with 
phosphorylation of NKCC1
The activity of NKCC1 and KCC2 can be modulated by
phosphorylation [26,27]. To test whether NKCC1 phos-
phorylation may contribute to the early rise of Cl- levels (<
3 hr), we stained 9 DRG sections from 3 animals with an
antibody raised specifically against the phosphorylated
form of NKCC1 (p-NKCC1). Preadsorption with a pep-
tide corresponding to the non-phosphorylated epitope
ensured the specificity of that immunosignal. The antisera
directed against NKCC1 (C-14 antibody) and p-NKCC1
showed a virtually perfect match in the DRG sections (Fig.
4A) indicating that both non-phosphorylated and phos-
phorylated forms of NKCC1 are present in most neurons.
However, in contrast to the NKCC1 immunosignal, the p-
NKCC1 signal responded rapidly and robustly to the
inflammatory mediators. Already after 1 hr, a significant
rise of the p-NKCC1 signal (+18% ± 5.9%; p ≤ 0.05) was
observed (Fig. 4B). Two hours after addition of the
inflammatory mediators, the p-NKCC1 signal was 45% (±
3.5%; p ≤ 0.001) above control, while the total expression
level of NKCC1 showed no response (Fig. 3). After 3
hours, the p-NKCC1 signal was increased by 54% (±
3.3%; p ≤ 0.001) relative to control DRGs. These data
demonstrate that the inflammatory mediators induce the
phosphorylation of NKCC1 in DRG neurons and suggest
that this phosphorylation causes the early (< 3 hr) phase
of enhanced Cl- accumulation observed by 2P-FLIM in
response to the stimulus.
Discussion
The goal of this study was to establish an in vitro assay that
monitors effects of inflammatory agents on chloride regu-
lation in DRG neurons. Since we are particularly inter-
ested in rapid changes of chloride accumulation and the
underlying dynamics of chloride transport proteins, we
developed a 3-hr protocol to obtain relevant data. We
have treated freshly dissected rat DRGs with a mixture of
inflammatory mediators representing the kinins (bradyki-
nin), the prostanoids (PGE2), the growth factors (NGF),
as well as ATP as a compound released from damaged tis-
sue, to create a medium similar to a site of inflammation.
The DRG neurons responded to this treatment with
increased expression of SP and CGRP, an effect character-
istic for the inflammatory response of peptidergic nocice-
ptors. For example, NGF can induce the expression of SP
and CGRP through activation of TrkA receptors, a major
pathway of neurotrophin-induced hyperalgesia [42]. DRG
neurons showed good viability during the 3-hr experi-
ments. The use of contralateral DRGs as controls in ourMolecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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Altered expression of Cl- transport proteins during treatment with inflammatory mediators Figure 3
Altered expression of Cl- transport proteins during treatment with inflammatory mediators. (A) Results from the 
segment-pair protocol where the mean immunofluorescence from each test DRG (FItest) is related to that of its contralateral 
control DRG (FIctr). The change of fluorescence intensity ΔFI = (FItest-FIctr)/FIctr·100 [%] is depicted 1 hr, 2 hr, and 3 hr of treat-
ment, respectively. The data show that 3 hr after the start of the treatment the expression of the Na+, K+, 2Cl- cotransporter 
NKCC1 is enhanced while that of the K+, Cl- cotransporter KCC2 is reduced. (B) A similar result was obtained in experiments 
where control DRGs and test DRGs were not obtained from the same vertebral segment, but were randomly combined. Indi-
cated significance levels are p ≤ 0.01 (**) and p ≤ 0.001 (***). Numbers in parentheses indicate cells evaluated.Molecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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"segment pair" protocol provided a suitable reference for
the statistical evaluation of the experiments.
Inflammatory mediators stimulate Cl- accumulation in 
DRGneurons
In a previous paper we have shown that [Cl-]i in mouse
DRG neurons shows a general decrease within the first
three postnatal weeks, as Cl- homeostasis undergoes a
maturation process [39]. The result of this process is a het-
erogeneous pattern of Cl- levels among the neurons in
each DRG. In the present paper we report that the intrac-
ellular Cl- levels are not static but that they can be raised
by inflammatory mediators. Our 2P-FLIM data indicate
that the mediators induce a uniform rise of intracellular
Cl- in most DRG neurons. We have not attempted to
obtain a quantitative calibration of absolute Cl- concen-
trations. Currently available calibration procedures rely
on the Cl-/OH- exchanger tributyltin [3,39-41]. This com-
pound can be used in isolated cells to dissipate Cl- gradi-
ents across the plasma membrane and to set intracellular
Cl- to known values. We have previously transferred the
2P-FLIM calibration obtained from isolated DRG neurons
to the evaluation of data recorded from intact DRGs [39].
This procedure yielded a broad distribution of [Cl-]i val-
ues, ranging from 20 – 100 mM in adult animals. A com-
parison of similar 2P-FLIM measurements with X-ray
microprobe analysis of [Cl-]i in olfactory sensory neurons
[41] suggested that the two sets of results could differ by ±
20 mM. For the present study we, therefore, attempted to
obtain a more direct calibration and used tributyltin in
intact DRGs. However, this did not lead to a satisfactory
protocol. Treatment with tributyltin did not produce uni-
form Cl- levels even in the superficial cell layer of the gan-
glia. Instead, the substance produced prolonged increases
of the intracellular Ca2+ concentration which may com-
promise the validity of the calibration. We suppose that
the satellite glial cells which wrap each neuron inside the
DRGs [43] prevent the calibration. However, in the
present study, we wanted to test the response of DRG neu-
rons to inflammatory mediators while leaving the cellular
context as intact as possible – including the satellite glial
cells. Our 2P-FLIM results are, therefore, qualitative. They
clearly demonstrate an increase of Cl- accumulation in
reponse to inflammatory mediators, but they do not give
information about which level of [Cl-]i is reached during
the experiments.
The rise of intracellular Cl- during treatment with inflam-
matory mediators points to a similiar shift in Cl- regula-
tion as observed in various injured neurons [19]. Thus,
Immunohistochemical analysis of NKCC1 phosphorylation Figure 4
Immunohistochemical analysis of NKCC1 phosphorylation. (A) A cryosection of a T9 DRG was co-stained with antisera raised 
against NKCC1 and p-NKCC1 after a 3-hr treatment with inflammatory mediators. The two antibodies showed an almost per-
fect co-staining. The calibration bar indicates 100 μm. (B) In contrast to the NKCC1 immunosignal, the p-NKCC1 signal 
increased already 1 hr after the start of the treatment. The change of p-NKCC1 immune fluorescence in treated DRGs (FItest) 
compared to the respective contralateral control DRGs (FIctr) is expressed as ΔFI = (FItest-FIctr)/FIctr·100 [%]. ΔFI (± SD; 3 ani-
mals) was 18 ± 5.9% (1 hr), 45 ± 3.5% (2 hr), and 54 ± 3.3% (3 hr). Indicated significance levels are p ≤ 0.05 (*) and p ≤ 0.001 
(***). Numbers in parentheses indicate cells evaluated.Molecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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cortical neurons [44,45] and hippocampal neurons
[46,47] show increased Cl- levels and loss of GABA-ergic
inhibition in connection with epilepsy. Moreover, nocice-
ptive lamina-I dorsal-horn neurons in a model of neuro-
pathic pain display a depolarized ECl due to increased Cl-
accumulation [31] and the consequent occurrence of exci-
tatory Cl- currents. A number of similar observations have
led to the concept that various forms of neurological dis-
orders are associated with increased Cl- accumulation and
with the resulting failure of GABAergic or glycinergic inhi-
bition [8]. In line with this notion, our 2P-FLIM measure-
ments suggest that inflammation boosts the excitatory
potential of Cl- currents in DRG neurons through an
increased efficiency of Cl- accumulation.
Differential effects of inflammatory mediators on Cl-
transporters
[Cl-]i levels in neurons essentially reflect the balance of Cl-
uptake by NKCC1 and Cl- extrusion by KCC2. While the
expression of NKCC1 in DRG neurons is well docu-
mented (e.g. [13] and references therein), there are con-
flicting results about the expression of KCC2. Several
authors have failed to detect KCC2-mRNA in DRGs by
PCR or in-situ  hybridization [24,30] while others have
documented both the KCC2 message and protein in
DRGs [23,39]. We consistently found a KCC2 PCR signal,
which was weaker than the NKCC1 signal, as well as a
reproducible KCC2 immune fluorescence which changed
in opposite direction to the NKCC1 signals upon treat-
ment with inflammatory mediators. We therefore assume
that the two transporters co-determine [Cl-]i both at low
levels in control DRGs and at high levels in treated DRGs.
The temporal correlation between the p-NKCC1 signal
and the rise of [Cl-]i suggests that Cl- uptake by NKCC1 is
enhanced within 1–2 hours after treatment with inflam-
matory mediators through phosphorylation of the Cl-
transporter. This rapid response may cause the rise of [Cl-
]i observed by 2P-FLIM two hours after the start of the
treatment. On a longer time scale (3 hr) the amount of
transporter proteins detectable in DRG neurons changed
significantly, as the NKCC1 immunosignal increased and
the KCC2 signal decreased. Interestingly, no changes in
mRNA levels were observed for either of the two trans-
porters. These data suggest that the inflammatory media-
tors cause posttranslational changes such as
phosphorylation and recruitment of Cl-  transporters.
Changes of gene transcription do not appear to contribute
to the altered Cl- regulation within the time frame of our
experiments. This finding is in good accordance with
recent results from nociceptive neurons of the dorsal
horn. Changes of Cl- regulation that led to disinhibition
of these spinal neurons and to referred mechanical hyper-
algesia involved a rapid and transient increase of NKCC1
phosphorylation followed by increased recruitment of
NKCC1 protein to the plasma membrane within 3 hours
[33]. In contrast, the KCC2 expression level in dorsal horn
neurons declines upon peripheral inflammation caused
by complete Freund's adjuvant injection [35]. KCC2
shows a very high turn-over rate at the plasma membrane
(50% of labeled KCC2 is removed from the plasma mem-
brane within 20 min in hippocampal neurons [48]) and,
therefore, represents a suitable target for processes that
regulate the rate of Cl- extrusion from the cell. Thus, the
DRG neurons in our assay recapitulate the disinhibition
process of dorsal-horn neurons by increasing Cl- uptake
and by attenuating Cl- extrusion.
Chloride accumulation and inflammatory hyperalgesia
In contrast to most neurons of the central nervous system,
the primary afferent neurons of the somatosensory and
the olfactory systems accumulate intracellular Cl- and,
hence, provide the basis for excitatory Cl- currents. Both
types of sensory neurons employ NKCC1 as major Cl-
uptake pathway [13,22,49], but experiments with
NKCC1-/- knock-out mice revealed that other Cl- trans-
porters, possibly including Cl-/HCO3
- exchangers, con-
tribute as well [13,50-52]. While the somatosensory and
olfactory sensory neurons share the propensity to main-
tain elevated intracellular Cl- levels, they differ in their
specific regime of Cl- handling. The olfactory sensory neu-
rons show uniform and efficient Cl- accumulation and
maintain their ECl near 0 mV [41,53]. Cl- ions are, conse-
quently, the main charge carriers of the olfactory receptor
current [51,54,55], and Cl- accumulation plays a domi-
nant role in the olfactory sensory response. In contrast,
the efficiency of Cl-  accumulation in DRG neurons
appears to be regulated. The ECl across the axonal mem-
brane of DRG neurons is more negative than in olfactory
neurons. Taking into account previously measured intrac-
ellular Cl- concentrations of DRG neurons in intact gan-
glia (20 – 100 mM [39]) or in primary culture (20 – 70
mM; [1-3,40,56]), ECl is expected to range between -50
and -10 mV. Importantly, this dynamic range of ECl com-
prises values where Cl- currents are not – or only mildly –
excitatory (-50 mV) and values with strong excitatory
power (-10 mV). A shift of ECl during inflammation can,
therefore, effectively control the electrical response of
DRG neurons.
Our data indicate that the effect of inflammatory media-
tors on [Cl-]i is not restricted to nociceptors, as DRG neu-
rons of all sizes respond. In which way could a general
increase of [Cl-]i in DRG neurons contribute to inflamma-
tory hyperalgesia? Both spinal and peripheral processes
are likely. The spinal afferents of nociceptors express
GABAA receptors which mediate PAD by conducting Cl-
efflux. When GABA is released from spinal interneurons,
a moderate depolarization occurs under normal condi-
tions and causes presynaptic inhibition of the nociceptor.
In primary afferent neurons originating from inflamed tis-Molecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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sue, the increased [Cl-]i levels may alter the response to
GABA. As a consequence of the increased driving force for
Cl- efflux, presynaptic depolarization is thought to be
faster and to promote excitation [4,5]. Thus, GABAergic
interneurons may facilitate spike generation and, hence,
synaptic transmission for afferent signals. Moreover, the
GABAergic interneurons could mediate lateral sensitiza-
tion between adjacent nociceptors, or between nocicep-
tors and low-threshold mechanoreceptors which also
increase their [Cl-]i, giving rise to secondary hyperalgesia
or allodynia, respectively. In any case, increasing presy-
natic [Cl-]i during inflammation is expected to strengthen
afferent sensory signals in DRG neurons and to support
hyperalgesia.
Little is known about the role of Cl- channels and Cl- cur-
rents in the peripheral sensory endings of DRG neurons.
Peripheral GABA can either inhibit or excite nociceptors,
depending on the GABA concentration. Cutaneous affer-
ent fibres respond to peripheral GABA application with
depolarization in various preparations. Ault and Hilde-
brand [9] developed an isolated rat spinal cord – tail prep-
aration and used ventral root reflex recordings to test
peripheral GABA effects. They found that application of
300 μM GABA to the tail skin evoked similar excitatory
responses as 3 μM capsaicin. The morphine-sensitivity of
this effect demonstrated that the GABA response was
mediated by nociceptors. Carlton and co-workes [10]
demonstrated the algogenic effect of peripheral GABA.
These authors found expression of the GABAA receptor
subunits α1 and β2/β3 in a subpopulation (10–14%) of
unmyelinated sensory fibers in cat skin. Moreover, injec-
tion of the GABAA agonist muscimol into the skin attenu-
ated formalin-induced nociceptive behaviors at low
concentrations, but enhanced such behaviors at higher
concentrations. Furthermore, a study of peripheral anal-
gesic effects of neuroactive steroids provided additional
evidence that GABAA receptors can contribute to periph-
eral antinociception [57]. While the precise role of periph-
eral GABA in the generation or modulation of nociceptive
signals remains to be explored, these findings point to a
bimodal function of GABA-induced Cl- currents in the
periphery. Small Cl- currents tend to attenuate nocicep-
tion, possibly by promoting the inactivation of voltage-
gated Na+ channels. Larger Cl- currents, however, can be
excitatory and can elicit nociceptive behavior. In this con-
text, an upregulation of peripheral [Cl-]i during inflamma-
tion is expected to potentiate excitatory GABAergic
potentials and to amplify the algogenic effect of periph-
eral GABA. Thus, both spinal and peripheral changes in
Cl- regulation appear to contribute to the modulation of
sensory responses in DRG neurons. Concepts for a role of
excitatory Cl- currents in nociception may be useful for
further studies of inflammatory hyperalgesia.
Conclusion
We have used an in vitro assay to examine effects of
inflammatory mediators on chloride homeostasis in rat
DRG neurons. We found that the intracellular Cl- concen-
tration rises within 2 hours of treatment. Immunohisto-
chemical experiments revealed that phosphorylation of
the Na+-K+-2Cl- cotransporter NKCC1 coincides with this
increase of Cl- levels. After 3 hours of treatment, the effi-
ciency of Cl- accumulation is further enhanced through
upregulation of NKCC1 expression and reduced expres-
sion of the K+-Cl- co-transporter KCC2. Our data demon-
strate an impact of inflammatory stimuli on Cl- regulation
in DRG neurons and support concepts for the role of Cl-
accumulation in the generation of hyperalgesia.
Methods
Tissue preparation and in vitro assay
Adult rats were anesthetized and killed by cervical trans-
section. All experimental procedures were performed in
accordance with the Animal Protection Law and the
guidelines and permissions of Heidelberg University. The
spinal column was prepared from its dorsal aspect. After
exposing the spinal cord with attached dorsal root ganglia
(DRG) and spinal nerves, thoracic and lumbal DRGs were
carefully excised and transferred into ice-cold extracellular
solution (ES solution: 140 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 2.5 mM CaCl2, 10 mM glucose, 10 mM HEPES, pH
7.4). Only DRGs with intact dura mater and residual seg-
ments of spinal nerves and nerve roots were used for the
subsequent experiments. For the in vitro inflammation
assay, DRGs were transferred to M10 medium, consisting
of Minimal Essential Medium (Sigma M2279) with 10%
fetal calf serum (Sigma, F7524), 1% glutamine-penicillin-
streptomycin (Sigma, G6784), and 1% non-essential
amino acids (Sigma, M7145). This medium was comple-
mented with inflammatory mediators (100 ng/ml NGF,
1.8 μM ATP, 0.9 μM bradykinin, and 1,4 μM PGE2), and
DRGs were treated at 37°C, 5% CO2, for 1 – 3 hours. Con-
trol DRGs were incubated in M10 medium without the
inflammatory mediators.
Vitality tests
Following the treatment or control periods, DRGs were
immobilized in 4% low-melting point agarose in aerated
ES solution on ice. Slices were prepared using a vibratome
(150 – 170 μm thick) which were then incubated either
with 1.5 μM propidium iodide in ES solution (Sigma
P4170; 1–2 min, room temperature) or in ES solution
containing 10 μM C12-resazurin (Invitrogen L34951 plus
1 mM probenicide; 10 – 15 min, 37°C). To stop the reac-
tion, sections were transferred to ES solution. Propidium
iodide can only enter dead or damaged cells where it inter-
calates in the DNA. This causes a shift of the emission
maximum from 590 nm to 617 nm and a 20 to 30-fold
increase of fluorescence. C12-resazurin is reduced to theMolecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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red fluorescent C12- resorufin by NADH only in living
cells.
Two-photon fluorescence-lifetime imaging microscopy(2P-
FLIM)
DRGs were loaded with the Cl- indicator dye MQAE (N-6-
methoxyquinolinium acetoethylester; Molecular Probes,
Invitrogen). The dye was dissolved at 5 mM in M10
medium, and DRGs were incubated for 1 hour (the 2nd or
3rd  hour of treatment with inflammatory mediators).
DRGs were then immobilized in 4% low-melting point
agarose in aerated bicarbonate solution (120 mM NaCl,
2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 1 mM
MgCl2, 2 mM CaCl2, pH 7.4, aerated with 95% O2/5%
CO2), and observed on the 2P-FLIM instrument at room
temperature. MQAE molecules reach the excited state
upon absorption of a single ultraviolet photon (λ = 375
nm) or, alternatively, the simultaneous absorption of two
infrared photons (λ = 750 nm). We used two-photon exci-
tation to achieve an optical resolution of ~0.5 μm (x/y
plane) and 1 μm (z axis). The infrared light used for two-
photon excitation caused no detectable photodamage,
even with the relatively long observation times of multi-
ple images with 1 min of illumination per image. For the
MQAE molecule, the dwell time in the excited singlet state
(the fluorescence lifetime, τ) is near 30 ns in water con-
taining 50 μM MQAE and is reduced by anions through
collisional quenching. The Cl- dependence of τ is
described by the Stern-Volmer relation (τ0/τ = 1 + KSV [Cl-
]i), where τ0 is the fluorescence lifetime in 0 mM Cl-, and
KSV, the Stern-Volmer constant, is a measure of the Cl-
sensitivity of MQAE. KSV has a value of 185 M-1 in water
but only 3 M-1 inside isolated DRG neurons [40]. This
reduced sensitivity of intracellular MQAE may result in
part from interactions of the dye with other soluble ani-
ons and from self-quenching of MQAE at concentrations
> 100 μM [40]. In the present study, we did not determine
KSV for the neurons in intact DRGs. We, therefore,
obtained only information about changes in intracellular
Cl-, but do not determine the absolute Cl- concentration.
The DRGs were placed on the stage of an upright fluores-
cence microscope (BX50WI; Olympus Optical, Japan) and
observed through a 60× water-immersion objective (n.a. =
0.9; Olympus Optical). Fluorescence was excited with 150
fs light pulses (λ = 750 nm) applied at sufficient intensity
to generate two-photon excitation. Light pulses were gen-
erated at a frequency of 75 MHz by a mode-locked Titan-
Sapphire laser (Mira 900; output power, > 500 mW;
Coherent, Santa Clara, USA), which was pumped by the
frequency-doubled output (532 nm) of a Nd-vanadate
laser (Verdi; Coherent). The laser light was directed
through the objective onto the DRGs at reduced power
(2.5 mW) using a beam scanner (TILL Photonics, Munich,
Germany). Fluorescence was recorded by photomultipli-
ers, and lifetime analysis was performed using electronics
(SPC-730; Becker & Hickl, Berlin, Germany) and software
(SPC7.22; Becker & Hickl) for time-correlated single-pho-
ton counting. DRGs which were not loaded with MQAE
did not produce background signals with this method.
Lifetime images were analyzed using SPCImage 1.8 and
2.6 (Becker & Hickl) and a self-made image analysis soft-
ware. A detailed description of the instrument is given
elsewhere [40]. Images were obtained by scanning the
excitation light focus through tissue layers 1 – 3 cells
below the dura mater. Mean values of Cl- concentrations
are given with standard deviations (± SD).
Immunohistochemistry
Following treatment (or control), DRGs were washed in
phosphate-buffered solution (PBS: 8.1 mM Na2HPO4, 1.9
mM NaH2PO4, 130 mM NaCl, pH 7.4) and then fixed in
PBS containing 4% paraformaldehyde for 30 min. After
three washing steps in PBS, the tissue was sequentially
dehydrated in 10% to 30% sucrose overnight. The DRGs
were then embedded in Tissue-Tek (Leica, Nussloch, Ger-
many) and frozen onto the cryostate stage (Leica CM 3050
S) and stored at -20°C. Cryosections (14 μm) were pre-
pared at -20°C and collected on coated slides (Super-
Frost®Plus, Menzel, Braunschweig, Germany). Sections
were air-dried for 30 min, post-fixed in 4% paraformalde-
hyde in PBS, washed three times in PBS and blocked in
5% ChemiBLOCKER™ (Millipore, Billerica, USA), 0,5%
Triton X100 in PBS. Primary antibodies were diluted in
the same buffer and incubated for 2 h. The following anti-
bodies and dilutions were used: goat anti-NKCC1, 1:20
(C-14, Santa Cruz Biotechnology, Heidelberg, #sc-
21547), goat anti-NKCC1, 1:20 (N-16; Santa Cruz, #sc-
21545), goat anti-KCC2, 1:20 (R-14, Santa Cruz, #sc-
19420), sheep anti-p-NKCC1, 1:20 (directed against the
phosphorylated sites Thr203+Thr207+Thr212 of human
NKCC1, The University of Dundee, Scotland, UK), rabbit
anti-substance P, 1:50 (PC232L, Oncogene Research, San
Diego), and rabbit anti-CGRP, 1:50 (PC205L, Oncogene
Research). After three washing steps in PBS, sections were
incubated for 90 min with fluorescent labeled secondary
antibodies: donkey anti-goat Alexa488 (Invitrogen, A-
11055, 1:500), donkey anti-goat Alexa568 (Invitrogen, A-
11057, 1:500), donkey anti-sheep Alexa488 (Invitrogen,
A-11015, 1:500), donkey anti-rabbit Alexa488 (Invitro-
gen, A-21206, 1:500). After three washing steps in PBS, a
0.3 μM DAPI solution (Fluka, #32670) was used to stain
the nuclei. Sections were coverslipped with Aqua Poly/
Mount (Polysciences, Warrington, USA) and analyzed
using a Nikon Eclipse 90i upright automated microscope
equipped with a Nikon DS-1QM CCD camera. The instru-
ment was used at the Nikon Imaging Center at the Univer-
sity of Heidelberg. No fluorescence signal was observed
upon omission of primary antibodies. To test for the spe-
cificity of primary antibodies, preadsorption controls
were performed for the NKCC1 (N-16) and the KCC2 (R-Molecular Pain 2008, 4:32 http://www.molecularpain.com/content/4/1/32
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14) polyclonal antibodies using a 5-fold excess of block-
ing peptides (0.05 μg/μl) according to the manufacturers
specifications. The specificity of the antibodies for NKCC1
(C-14) and p-NKCC1 were confirmed by co-staining with
NKCC1 (N-16).
Semi-quantitative RT-PCR
Total RNA was extracted from DRGs after various dura-
tions of treatment with inflammatory mediators, follow-
ing an established protocol [58]. After DNase I treatment
(RNase-free, Fermentas, StLeon-Rot, Germany) cDNA was
synthesized from 5 μg total RNA using an oligo-dT primer
and Superscript™ III reverse transcriptase (Invitrogen)
according to the manufacturer's instructions. The cDNA
was quantified for normalization using PCR (22 to 35
cycles) with β-actin primers. The annealing temperature
for all primers was 58°C. Semiquantitative PCR amplifi-
cation was performed on 0.5 μl single-stranded cDNA
product with 2U Taq DNA polymerase (Fermentas). The
cycling conditions were 94°C for 3 min, 94°C for 30 s,
58°C for 30 sec, 72°C for 1 min for 28 and 32 cycles,
respectively, and 72°C for 8 min. Primer pairs were:
NKCC1/F 5'CGA ATT ATT GGA GCC ATT ACA GT3',
NKCC1/R 5'ACA TCT GGA AAG CTG GGT AGA TA3',
KCC2/F 5'GTC TCT GGG CCC GGA GTT T3', KCC2/R
5'GGC ATC CCG CAG GTC TC3'. For positive controls
and normalization β-actin primer pairs were: actin/F
5'GGT CAT CAC TAT CGG CAA TGA GC3', actin/R 5'GGA
CAG TGA GGC CAG GAT AGA GC3'. The resulting PCR
products were cloned into pGMT vector (Promega, Man-
nheim, Germany) and sequenced.
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